Tuberkuloz ve Toraks-Tuberculosis and Thorax

Scope & Guideline

Fostering dialogue on thoracic health challenges.

Introduction

Welcome to the Tuberkuloz ve Toraks-Tuberculosis and Thorax information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Tuberkuloz ve Toraks-Tuberculosis and Thorax, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageMulti-Language
ISSN0494-1373
PublisherTURKISH ASSOC TUBERCULOSIS & THORAX
Support Open AccessNo
CountryTurkey
TypeJournal
Convergefrom 2003 to 2024
AbbreviationTUBERK TORAK / Tuberk. Toraks
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressC/O AKIN KAYA MD, PROFESSOR, DEPT CHEST DISEASES, FAC MEDICINE, ANKARA 06100, Turkiye

Aims and Scopes

The journal 'Tuberkuloz ve Toraks-Tuberculosis and Thorax' focuses on a broad spectrum of respiratory diseases, with a particular emphasis on tuberculosis and related pulmonary conditions. Its aims include advancing knowledge in the field through clinical studies, reviews, and innovative research methodologies.
  1. Tuberculosis Research:
    A core focus of the journal is on tuberculosis, including its diagnosis, treatment, and complications. Studies often explore novel therapeutic approaches and public health strategies to combat TB.
  2. Respiratory Disease Management:
    The journal covers various aspects of managing chronic respiratory diseases such as asthma, COPD, and interstitial lung diseases, emphasizing clinical outcomes and patient management strategies.
  3. Pulmonary Pathophysiology and Diagnostics:
    Research on the underlying pathophysiological mechanisms of respiratory diseases, alongside advances in diagnostic techniques like imaging and biomarkers, is a consistent theme.
  4. COVID-19 Impact and Related Respiratory Conditions:
    Given the recent pandemic, there is a significant focus on the effects of COVID-19 on respiratory health, including long-term sequelae and management strategies.
  5. Innovative Therapeutics and Technologies:
    The journal promotes studies on the latest therapeutic innovations, including biologics and personalized medicine, particularly in the treatment of severe asthma and other chronic conditions.
Recent years have seen the emergence of new themes within the journal, reflecting current trends in respiratory medicine and public health. These topics highlight the evolving landscape of research priorities.
  1. Long COVID and Post-COVID Conditions:
    There is a growing body of literature addressing the long-term effects of COVID-19, including post-COVID syndrome, which is crucial for understanding and managing ongoing respiratory issues.
  2. Telemedicine and Remote Patient Monitoring:
    The shift towards telemedicine, particularly during and after the pandemic, has led to increased research on its effectiveness in managing respiratory diseases and enhancing patient care.
  3. Biologics and Targeted Therapies:
    Research on the use of biologics for severe asthma and other conditions is on the rise, reflecting a trend towards personalized medicine and targeted treatment approaches.
  4. Impact of Environmental Factors on Respiratory Health:
    Emerging studies explore how environmental factors, such as air pollution and climate change, affect respiratory health, indicating a significant shift towards public health and environmental health intersections.
  5. Artificial Intelligence in Pulmonology:
    The application of AI and machine learning in diagnosing and managing respiratory diseases is gaining traction, with studies focusing on its potential to enhance diagnostic accuracy and treatment outcomes.

Declining or Waning

While the journal maintains a diverse range of topics, certain themes have seen a decline in recent publications. These areas may reflect shifting research priorities or reduced interest in specific methodologies or conditions.
  1. Traditional Epidemiological Studies:
    There appears to be a decline in traditional epidemiological studies focused solely on the prevalence of respiratory diseases, as newer methodologies and technologies gain traction.
  2. Basic Science Research on Respiratory Diseases:
    Research that emphasizes basic science or laboratory studies without direct clinical application has become less prominent, as the journal increasingly prioritizes studies with immediate clinical relevance.
  3. Niche Respiratory Conditions:
    Coverage of less common respiratory conditions, such as rare lung diseases, has diminished in favor of more prevalent conditions and those with greater public health impact.

Similar Journals

Respiratory Medicine and Research

Illuminating the path to respiratory wellness.
Publisher: ELSEVIERISSN: Frequency: 2 issues/year

Respiratory Medicine and Research, published by Elsevier, is a pivotal journal in the field of Pulmonary and Respiratory Medicine, dedicated to advancing the understanding and treatment of respiratory diseases. Since its inception in 2019, the journal has provided a platform for high-quality research, contributing significantly to the scientific community's knowledge base, as reflected in its impressive Q2 categorization in 2023. With a Scopus rank of #94 out of 155, placing it in the 39th percentile, this journal is essential for researchers, professionals, and students seeking the latest advancements in respiratory medicine. Although currently categorized as a non-open access publication, it remains accessible to those affiliated with institutions with subscriptions. Published in France, the journal aims to foster collaboration and innovation by highlighting original research, clinical studies, and comprehensive reviews that address pressing issues in respiratory health.

RESPIRATORY RESEARCH

Bridging Research and Clinical Excellence in Respiratory Care
Publisher: BMCISSN: Frequency: 1 issue/year

RESPIRATORY RESEARCH is a leading open-access journal published by BMC, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2000, this journal has provided a vital platform for disseminating high-quality research, covering a broad spectrum of topics from basic science to innovative clinical practices in respiratory health. With an impressive impact factor and a Q1 ranking in the Pulmonary and Respiratory Medicine category, RESPIRATORY RESEARCH is recognized for its significant contribution to the literature, currently positioned at rank #19 out of 155 in the Scopus database, highlighting its relevance and influence within the medical community. The journal’s commitment to open access ensures that all articles are freely available to researchers, professionals, and students, fostering collaboration and knowledge sharing in the field. With its convergence years spanning from 2000 to 2024, RESPIRATORY RESEARCH remains at the forefront of respiratory medicine research, making it an essential resource for all stakeholders in this vital medical domain.

European Respiratory Review

Elevating Standards in Pulmonary Research and Review
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 0905-9180Frequency: 4 issues/year

European Respiratory Review is a prestigious peer-reviewed journal published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, specializing in the dynamic field of pulmonary and respiratory medicine. With an impact factor that places it among the top quartile journals in its category (Q1), as indicated by its impressive Scopus rank of #7 out of 155, it serves as a critical platform for disseminating high-quality research and innovative reviews in the field. As an Open Access journal since 2005, it ensures that cutting-edge findings are readily available to a global audience, promoting greater transparency and collaboration within the academic community. Published from Switzerland, European Respiratory Review covers a broad spectrum of topics from clinical advancements to emerging trends, making it an essential resource for researchers, healthcare professionals, and students committed to advancing respiratory health. The journal's history, dating back to 1992, reflects a steadfast commitment to fostering scholarly exchange and driving forward the frontiers of knowledge within respiratory medicine.

Annals of the American Thoracic Society

Exploring new frontiers in pulmonary health and clinical excellence.
Publisher: AMER THORACIC SOCISSN: 1546-3222Frequency: 12 issues/year

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

EUROPEAN RESPIRATORY JOURNAL

Elevating Knowledge in Pulmonary Medicine
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 0903-1936Frequency: 12 issues/year

The EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.

Lancet Respiratory Medicine

Exploring new horizons in respiratory medicine.
Publisher: ELSEVIER SCI LTDISSN: 2213-2600Frequency: 12 issues/year

The Lancet Respiratory Medicine, published by Elsevier in the United Kingdom, is a premier journal dedicated to the field of pulmonary and respiratory medicine. With its impressive impact factor and a prestigious ranking of #1 out of 155 in its category as of 2023, it holds a remarkable position in advancing research and clinical practices in respiratory health. The journal invites original research, reviews, and clinical studies that aim to propel the understanding of respiratory diseases, fostering innovations in treatment and management strategies. Operating under a Q1 category in Scopus rankings, it is an essential platform for researchers, healthcare professionals, and students who are committed to enhancing patient care and advancing knowledge in this crucial area of medicine. The Lancet Respiratory Medicine remains a vital resource for the latest findings and discussions shaping the future of respiratory health.

Respiratory Investigation

Shaping tomorrow's respiratory practices today.
Publisher: ELSEVIERISSN: 2212-5345Frequency: 6 issues/year

Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.

Multidisciplinary Respiratory Medicine

Unlocking the potential of respiratory research for global impact.
Publisher: MATTIOLI 1885ISSN: 1828-695XFrequency: 1 issue/year

Multidisciplinary Respiratory Medicine is a leading open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by MATTIOLI 1885, this journal has been serving the academic community since 2008 and has become a vital platform for the dissemination of research and clinical insights in this critical area of healthcare. With an impressive impact factor placing it in the Q2 category of pulmonary medicine in 2023 and a Scopus rank of #67 out of 155, it reflects a solid commitment to high-quality research. The journal provides researchers, health professionals, and students with accessible and updated information, fostering collaboration and advancement in respiratory health. Operating from the United Kingdom, it has embraced open access since 2010, ensuring that all articles are freely available, thus maximizing the reach and impact of its scholarly contributions. Whether you are looking to publish innovative findings or gain insights from industry leaders, Multidisciplinary Respiratory Medicine is your go-to resource for the latest in respiratory science.

Breathe

Transforming respiratory care through scholarly discourse.
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 1810-6838Frequency: 4 issues/year

Breathe, published by the European Respiratory Society Journals Ltd, is a prominent open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. With an ISSN of 1810-6838 and an E-ISSN of 2073-4735, this journal has been contributing to scholarly discourse since 2008. Nestled in the United Kingdom, it serves as a vital platform for researchers, clinicians, and educators, particularly in the areas of respiratory pathophysiology, diagnostic methods, and therapeutic interventions. Currently classified in the third quartile (Q3) for pulmonary and respiratory medicine, Breathe ranks 91st out of 155 in Scopus, reflecting its growing influence in the discipline. The journal aims to publish high-quality, peer-reviewed research that fosters collaboration and innovation in lung health, making significant strides toward improving patient outcomes. Whether you are a seasoned professional or an up-and-coming researcher, Breathe offers a wealth of knowledge and resources to support your work in this crucial area of medicine.

Lung India

Transforming respiratory healthcare with every publication.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-2113Frequency: 6 issues/year

Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.